PNL8 ASSESSING THE COST-EFFECTIVENESS OF IMMUNOMODULATORYTHERAPIES FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS BASED ON LONG-TERM DATA
Abstract
Authors
CF Bell JB Graham SR Earnshaw M Oleen-Burkey J Castelli-Haley KP Johnson